{ "cik": 1831915, "cik_padded": "0001831915", "entityName": "Cytek Biosciences, Inc.", "fiscal_years": [ { "accn": "0001628280-26-012352", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 15074000.0, "capex": 4084000.0, "cash": 90853000.0, "cost_of_revenue": 97033000.0, "free_cash_flow": -8770000.0, "gross_profit": 104460000.0, "net_income": -66539000.0, "operating_cash_flow": -4686000.0, "operating_income": -40384000.0, "revenue": 201493000.0, "stockholders_equity": 341739000.0, "total_assets": 461542000.0, "total_liabilities": 119803000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5184299206424045, "leverage": 0.3505687088684639, "net_margin": -0.3302298342870472, "operating_margin": -0.20042383606378386, "revenue_growth_yoy": 0.0051882486168827605, "roa_avg2y": -0.13847261618118667, "roa_period_end": -0.1441667280550849, "roe_avg2y": -0.18045061805401125, "roe_period_end": -0.19470707177114696 } }, { "accn": "0001628280-26-012352", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 21611000.0, "capex": 3525000.0, "cash": 98716000.0, "cost_of_revenue": 89347000.0, "free_cash_flow": 21854000.0, "gross_profit": 111106000.0, "net_income": -6020000.0, "operating_cash_flow": 25379000.0, "operating_income": -20523000.0, "revenue": 200453000.0, "stockholders_equity": 395737000.0, "total_assets": 499500000.0, "total_liabilities": 103763000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5542745681032462, "leverage": 0.26220191692967804, "net_margin": -0.030031977570802133, "operating_margin": -0.10238310227335086, "revenue_growth_yoy": 0.03853586508820558, "roa_avg2y": -0.01211320006801099, "roa_period_end": -0.012052052052052054, "roe_avg2y": -0.0152636723330726, "roe_period_end": -0.015212123203036358 } }, { "accn": "0001628280-26-012352", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 44151000.0, "capex": 4648000.0, "cash": 167299000.0, "cost_of_revenue": 83589000.0, "free_cash_flow": 633000.0, "gross_profit": 109426000.0, "net_income": -12148000.0, "operating_cash_flow": 5281000.0, "operating_income": -27845000.0, "revenue": 193015000.0, "stockholders_equity": 393064000.0, "total_assets": 494457000.0, "total_liabilities": 101393000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5669300313447141, "leverage": 0.257955447458938, "net_margin": -0.06293811361811258, "operating_margin": -0.1442633992176774, "revenue_growth_yoy": 0.17666243995220562, "roa_avg2y": -0.02396213556517048, "roa_period_end": -0.024568364893206084, "roe_avg2y": -0.029679578798206718, "roe_period_end": -0.030905908452567524 } }, { "accn": "0001628280-25-008780", "filed": "2025-02-28", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 9748000.0, "cash": 296601000.0, "cost_of_revenue": 63062000.0, "free_cash_flow": -21979000.0, "gross_profit": 100974000.0, "net_income": 2484000.0, "operating_cash_flow": -12231000.0, "operating_income": -1804000.0, "revenue": 164036000.0, "stockholders_equity": 425546000.0, "total_assets": 519476000.0, "total_liabilities": 93930000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6155599990246043, "leverage": 0.22072819389678203, "net_margin": 0.01514301738642737, "operating_margin": -0.010997585895778976, "revenue_growth_yoy": 0.2820320437670965, "roa_avg2y": 0.005055042781657358, "roa_period_end": 0.00478174160115193, "roe_avg2y": 0.005978835787809096, "roe_period_end": 0.005837206788455302 } }, { "accn": "0001628280-25-008780", "filed": "2025-02-28", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 4364000.0, "cash": 364618000.0, "cost_of_revenue": 48806000.0, "free_cash_flow": 266000.0, "gross_profit": 79144000.0, "net_income": 3027000.0, "operating_cash_flow": 4630000.0, "operating_income": 9157000.0, "revenue": 127950000.0, "stockholders_equity": 405385000.0, "total_assets": 463305000.0, "total_liabilities": 57920000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6185541227041813, "leverage": 0.14287652478508084, "net_margin": 0.02365767878077374, "operating_margin": 0.07156701836654944, "revenue_growth_yoy": 0.37819235450618816, "roa_avg2y": 0.00886015185486562, "roa_period_end": 0.006533493055330721, "roe_avg2y": 0.015548712364231283, "roe_period_end": 0.007466975837783834 } }, { "accn": "0001628280-24-010933", "filed": "2024-03-13", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1547000.0, "cash": 165231000.0, "cost_of_revenue": 41129000.0, "free_cash_flow": 13609000.0, "gross_profit": 51710000.0, "net_income": 19411000.0, "operating_cash_flow": 15156000.0, "operating_income": 13659000.0, "revenue": 92839000.0, "stockholders_equity": -16028000.0, "total_assets": 219979000.0, "total_liabilities": 41688000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.5569857495233684, "net_margin": 0.20908238994388134, "operating_margin": 0.1471256691692069, "roa_period_end": 0.0882402411139245, "roe_avg2y": 1.5121723211155689 } }, { "accn": "0000950170-23-005610", "filed": "2023-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": 41701000.0 }, "period_end": "2019-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001628280-26-012352", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3826", "sic_description": "Laboratory Analytical Instruments", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001831915.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001831915.json" }, "ticker": "CTKB" }